Treatment for Hepatitis C is dependant on the genotype of the virus. There is a new treatment for Hep C genotype 1 – The most common genotype in America. This strain of the virus can consist of either genotype 1a or genotype 1b.
A majority of the time, these treatments are eight to 16 weeks in length and should be followed up with further testing, in case of relapse.
Hep C genotype 1 treatment can come in the form of injections, solutions, and tablets or capsules. Injections may be painful and tend to have more side-effects, so many people tend to prefer tablets, capsules or solutions.
Here is a list of the several different medications which constitute the new treatment for Hep C Genotype 1:
Daklinza (daclatasvir) with Sovaldi (): this combination will treat the Hep C virus directly. It is usually given as a 12-week treatment, taken once a day, with side effects that include headaches and fatigue.
Epclusa (/velpatasvir): Epclusa comes in the form of a tablet that is taken on once a day for a 12-week period. A patient can take the tablet with or without food, but common side effects also include headaches and fatigue.
(ledipasvir/): the recommended dosage for this treatment is one tablet per day. Treatment length varies from eight to 12 or 24 weeks. Headaches and fatigue were reported as the main side effects of .
Pak (ombitasvir/paritaprevir/ tablets; tablets): This treatment is a combination of tablets taken over the course of 12 to 24 weeks. Two tablets of ombitasvir/paritaprevir/ are taken once a day in the morning, and one tablet of is taken twice a day – morning and evening. The Pak treatment must be taken with food. If a patient has the Hep C genotype 1a, this treatment is usually given with a solution of ribavirin. Side effects also include headaches, nausea and fatigue.
Patients should consult their doctor or healthcare provider over which treatment would be best suited for them.
Featured Image: DepositPhotos/KomokvmPosted on May 5, 2023